Concepedia

Author

Mohammad Ghani

The University of Texas Health Science Center at Houston

Also Known As

M Ghani, M. Ghani, Mohammad Ghani, Mohammad K Ghani, Mohammad K. Ghani

15

Publications

605

Citations

9

H-Index

23

Concepts

All Affiliations

The University of Texas Health Science Center at HoustonMemorial Hermann
MG

About

Mohammad Ghani is an author at The University of Texas Health Science Center at Houston specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

239

2

Emergency Medicine

3

3

160

3

Pharmacology

2

2

79

4

Nephrology

1

1

48

5

Orthopaedics

1

1

45

Mohammad Ghani

×

8

Publications

582

Citations

8

H-Index

YearCitations

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease

Prakash Krishnan, Peter L. Faries, Khusrow Niazi,

Circulation

2017

210

Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of ?no reflow? phenomenon

Abid Assali, Stefano Sdringola, Mohammad Ghani,

Catheterization and Cardiovascular Interventions

2000

99

Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon

Stefano Sdringola, Abid Assali, Mohammad Ghani,

Catheterization and Cardiovascular Interventions

2000

74

The dilemma of success: Percutaneous coronary interventions in patients ≥ 75 years of age—successful but associated with higher vascular complications and cardiac mortality

Abid Assali, Ali Moustapha, Stefano Sdringola,

Catheterization and Cardiovascular Interventions

2003

59

Right atrial thrombus formation associated with central venous catheters utilization in hemodialysis patients

Mohammad Ghani, Fernando Boccalandro, Ali E. Denktas,

Intensive Care Medicine

2003

48

Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices

Abid Assali, Stefano Sdringola, Ali Moustapha,

Catheterization and Cardiovascular Interventions

2002

45

Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban)

Abid Assali, Joseph Salloum, Stefano Sdringola,

The American Journal of Cardiology

2001

34

Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention

Ibrahim E. Fahdi, Jorge F. Saucedo, Thomas A. Hennebry,

The American Journal of Cardiology

2004

13

Page 1